BayWa’s, Clock

BayWa’s Clock Ticks Down to a Crucial April 30 Payment as Goldman Sachs Struggles to Sell the Kiwi Unit

Published on 04/27/2026 at 15:20 | Redaktion boerse-global.de

BayWa awaits a €107M payment from Cefetra sale and a lender standstill vote, as a €2.7B deleveraging gap and stalled asset sales deepen its restructuring crisis.

BayWa’s Clock Ticks Down to a Crucial April 30 Payment as Goldman Sachs Struggles to Sell the Kiwi Unit Illustration mit AI erstellt übermittelt durch boerse-global.de
BayWa’s Clock Ticks Down to a Crucial April 30 Payment as Goldman Sachs Struggles to Sell the Kiwi Unit Illustration mit AI erstellt übermittelt durch boerse-global.de

The next few days will determine whether BayWa can buy itself more breathing room or face a sudden collapse of its restructuring plan. The German agricultural conglomerate is waiting for a €107 million payment from the sale of its Dutch subsidiary Cefetra, due by April 30. If the cash arrives on time, it strengthens management’s hand in parallel talks with its core lenders.

DZ Bank and HVB are currently voting on whether to extend a standstill agreement into the autumn. Rejection would strip the restructuring plan of its legal foundation immediately. The pressure is acute: the shares tumbled more than 9% on Monday to €13.05, extending their year-to-date loss to 22%.

A €2.7 Billion Hole That Asset Sales Can’t Fill

The numbers tell a grim story. BayWa needs to deleverage by €4 billion by 2028, but has only secured €1.3 billion so far through disposals. That leaves a gaping €2.7 billion shortfall. The biggest piece of the puzzle fell away when the US scrapped subsidies for renewable energy, killing the planned sale of the BayWa r.e. energy division.

All eyes are now on New Zealand. Goldman Sachs has been running a bidding process since March for BayWa’s 74% stake in apple marketer T&G Global. The target price is around €300 million, with private equity firms such as Roc Partners and Paine Schwartz among the interested parties. But the process is stalling. A minority shareholder from Hong Kong, holding roughly a fifth of the shares, is complicating negotiations.

Should investors sell immediately? Or is it worth buying BayWa?

Even a successful sale would only be a drop in the ocean. The €107 million from Cefetra, due this week, provides some short-term relief but does little to close the structural gap.

Legal Storms Gather on Two Fronts

Beyond the balance sheet, BayWa faces mounting legal exposure. The law firm TILP is preparing damages claims based on a BaFin reprimand, alleging that the company failed to disclose significant refinancing risks in its 2023 management report. Meanwhile, the audit watchdog Apas is investigating former auditor PwC for allegedly concealing existential risks.

PwC is finalising its last audit of BayWa’s past financial year, but the report will be delayed until the fourth quarter of 2026 because of a mandatory revaluation of the energy subsidiary. The company is also tendering the audit mandate for 2026 onwards.

BayWa at a turning point? This analysis reveals what investors need to know now.

Cost Cuts and a Q1 Test

Management is responding with a brutal cost-cutting programme. BayWa is eliminating 1,300 jobs and closing 26 branches. The market will get its first look at the results on May 6, when the first-quarter report is due. Investors will be watching for concrete evidence that costs are coming down.

The operating result target for 2027 is around €140 million on a clean basis. But that assumes the restructuring plan holds together. With the standstill vote looming, the Cefetra payment due, and the T&G sale stuck in limbo, BayWa is running out of time to prove it can navigate this crisis.

Ad

BayWa Stock: New Analysis - 27 April

Fresh BayWa information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BayWa analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0005194005 | BAYWA’S | boerse | 69249080 |